Bictegravir/Lenacapavir

bictegravir/lenacapavir · Gilead Sciences

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Bictegravir/Lenacapavir, covering 2025-11-05 to 2026-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Study of Bictegravir/Lenacapavir in Children and Adolescents With HIV-1 [Phase 2, Phase 3]